Loading…
Charming Medical Limited is projected to rise to $42.21 by 2027, a +44% move from its current price of $29.36. MCTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $28.85 | $29.36 | $29.88 | +0.01% |
| May 30 | $28.64 | $29.36 | $30.10 | +0.02% |
| May 31 | $28.49 | $29.36 | $30.27 | +0.03% |
| Jun 1 | $28.36 | $29.37 | $30.42 | +0.04% |
| Jun 2 | $28.24 | $29.37 | $30.55 | +0.06% |
| Jun 3 | $28.14 | $29.37 | $30.66 | +0.07% |
| Jun 4 | $28.05 | $29.38 | $30.77 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $28.05 | $29.38 | $30.77 | +0.08% |
| Week 2 | $27.53 | $29.40 | $31.40 | +0.16% |
| Week 3 | $27.15 | $29.42 | $31.89 | +0.24% |
| Week 4 | $26.84 | $29.45 | $32.31 | +0.32% |
| Week 5 | $26.57 | $29.47 | $32.69 | +0.39% |
| Week 6 | $26.32 | $29.49 | $33.05 | +0.47% |
| Week 7 | $26.11 | $29.52 | $33.37 | +0.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Charming Medical Limited operates beauty, wellness, and postpartum services under the Beauty Lab brand in Hong Kong.
Its services include womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine-inspired prenatal massage, and Indonesian traditional abdominal binding. It also markets TCM-inspired supplements and beauty products, and provides consultancy services and training to other beauty salons and wellness centers.
The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong, and it sits in the Healthcare category.
Charming Medical Limited (MCTA) is a healthcare company listed in the referenced universe. It currently trades at $29.36, with a market capitalization of $504.26M and a rank of 3036.
The price outlook available from the forecast shows a multi-year path of growth, with the 2026 avg price listed at $29.36 and the 2050 avg price projected at $687.57, with a max of $1,288.92. This implies a substantial long-run upside relative to the current price.
Forecasts indicate a rising trajectory across years, with 2027 avg $42.21, 2028 avg $55.06, 2029 avg $71.44, and 2030 avg $84.10, extending to 2050 avg $687.57. The forecast also shows widening ranges by year, reflecting higher potential highs and the associated risk.
A major floor 0.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major level 0.0% below — it may now act as a floor.
Key MCTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.35 | Buy | $29.35 | Buy |
| MA 10 | $29.35 | Buy | $29.35 | Buy |
| MA 20 | $29.35 | Buy | $29.35 | Buy |
| MA 50 | $29.35 | Buy | $29.28 | Buy |
| MA 100 | $29.35 | Buy | $28.04 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 78.51 | Sell |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -66.67 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.00 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 50.00 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 0.00 | Neutral |
| Hull MA (9) | 29.35 | Buy |
| ADX (14) | 57.02 | Buy |
| ATR (14) | 0.00 | Info |
The near-term technical picture shows a neutral stance with an elevated RSI. RSI14 is 80, and the 50-day simple moving average (SMA50) is $29.35, with support and resistance both at $29.35.
The 30-day price range spans from $26.11 to $33.00, indicating a relatively tight trading band around the current level. The asset is described with a neutral sentiment and an annualized volatility of 30, reflecting meaningful but contained near-term risk.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.35 | $29.36 | $41.38 | 0% | Neutral | |
| $33.36 | $42.21 | $56.64 | +44% | Bullish | |
| $41.94 | $54.58 | $75.99 | +86% | Bullish | |
| $53.35 | $71.09 | $101.88 | +142% | Bullish | |
| $61.98 | $84.34 | $123.88 | +187% | Bullish | |
| $64.26 | $89.14 | $133.78 | +204% | Bullish | |
| $75.28 | $106.31 | $162.66 | +262% | Bullish | |
| $85.41 | $122.67 | $191.00 | +318% | Bullish | |
| $96.18 | $140.36 | $222.10 | +378% | Bullish | |
| $121.36 | $179.85 | $288.88 | +513% | Bullish | |
| $173.15 | $275.19 | $470.68 | +837% | Bullish | |
| $383.04 | $687.13 | $1,287.96 | +22.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $29.35 | $29.36 | $34.61 | +0.00% |
| June 2026 | $25.34 | $29.78 | $35.84 | +1.44% |
| July 2026 | $25.02 | $29.66 | $36.20 | -0.40% |
| August 2026 | $25.67 | $30.64 | $37.80 | +3.31% |
| September 2026 | $26.44 | $31.74 | $39.50 | +3.58% |
| October 2026 | $26.20 | $31.61 | $39.66 | -0.39% |
| November 2026 | $26.05 | $31.58 | $39.88 | -0.11% |
| December 2026 | $26.73 | $32.55 | $41.38 | +3.07% |
Click any year to see its month-by-month MCTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Charming Medical Limited's 2026 outlook centres on $29.36, within a $29.35 to $41.38 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MCTA could reach as high as $56.64, with a base case around $42.21 and support toward $33.36 — roughly +44% from $29.36. Buyers look set to stay in control over this stretch.
Expect MCTA to range from $41.94 to $75.99 through 2028. The $54.58 average target implies a +86% move from current prices. That is up +29% on the projected 2027 average. Momentum favours further upside here.
The MCTA price prediction for 2029 points to an average of $71.09 (low $53.35, high $101.88) — a potential gain of +142% on today's $29.36. Buyers look set to stay in control over this stretch.
In 2030, MCTA is projected to trade between $61.98 and $123.88, averaging $84.34 — a potential gain of +187% from today's $29.36. That is up +19% on the projected 2029 average. Momentum favours further upside here.
Charming Medical Limited's 2031 outlook centres on $89.14, within a $64.26 to $133.78 range. That is up +6% on the projected 2030 average. That marks a +204% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, MCTA could reach as high as $162.66, with a base case around $106.31 and support toward $75.28 — roughly +262% from $29.36. Momentum favours further upside here.
Expect MCTA to range from $85.41 to $191.00 through 2033. The $122.67 average target implies a +318% move from current prices. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The MCTA price prediction for 2034 points to an average of $140.36 (low $96.18, high $222.10) — a potential gain of +378% on today's $29.36. Momentum favours further upside here.
In 2035, MCTA is projected to trade between $121.36 and $288.88, averaging $179.85 — a potential gain of +513% from today's $29.36. That is up +28% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Charming Medical Limited's 2040 outlook centres on $275.19, within a $173.15 to $470.68 range. That is up +53% on the projected 2035 average. That marks a +837% change versus current levels. Momentum favours further upside here.
By 2050, MCTA could reach as high as $1,287.96, with a base case around $687.13 and support toward $383.04 — roughly +22.4x from $29.36. Buyers look set to stay in control over this stretch.
Investing $1,000 in MCTA today (≈ 34.065747 MCTA) could be worth
$23,407.61
+$22,407.61 (+2241%) by 2050 · US Dollar
Based on the average projected MCTA price of $687.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCTAwould be worth at today's price.
$1,000 invested in MCTA on Oct 21, 2025 (≈ 142.857143 MCTA) would be worth
$4,193.57
+$3,193.57 (+319.4%) today · 4.19× · US Dollar
Based on a MCTA entry price of $7 vs. today's $29.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.35 | $1,000 | +0.0% |
| 1 month ago | $29.35 | $1,000 | +0.0% |
| 3 months ago | $29.35 | $1,000 | +0.0% |
| 6 months ago | $29.35 | $1,000 | +0.0% |
| All time ago | $7 | $4,193.57 | +319.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCTA forecast.
Our base-case forecast reaches $59.00 around 2029.
Implied market cap at $59.00: $895.5M
Over the multi-year horizon, the forecast depicts a bullish trajectory. In 2030, the avg price is $84.10, with a min of $61.79 and a max of $123.57 (ROI 186.5) and a bullish sentiment. By 2040, the avg rises to $276.69 (min $174.07, max $473.32; ROI 842.6) with continued bullishness.
By 2050, the avg is $687.57 (min $383.22, max $1,288.92; ROI 2242.3) and the sentiment remains bullish.
The path from 2027 onward shows progressively higher averages, from 2027 avg $42.21 to 2028 avg $55.06 and 2029 avg $71.44, culminating in the 2030 avg $84.10 before continuing higher into 2040 and 2050. These are estimates and not guarantees, and the forecast includes a wide range of potential outcomes across years.
Tap a question to reveal the answer.
Avg $84.10, min $61.79, max $123.57 (these values are the 2030 forecast).
Forecasts suggest a bullish sentiment from 2027 onward, with rising averages such as 2027 avg $42.21, 2028 avg $55.06, 2029 avg $71.44, 2030 avg $84.10, and 2050 avg $687.57. These are estimates, not guarantees, and current price is $29.36.
Yes. The forecast max reaches $102.43 in 2029 and extends higher in later years (e.g., 2030 max $123.57; 2033 max $190.98; 2034 max $223.10; 2035 max $290.34; 2040 max $473.32; 2050 max $1,288.92).
Current price is $29.36 and market cap is $504.26M.
30-day range is $26.11 to $33.00; RSI14 is 80; SMA50 is $29.35; support and resistance are $29.35; sentiment is NEUTRAL; annualized volatility is 30.
Charming Medical Limited Community Discussion
0Share your Charming Medical Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.